Stock SGBCF SHANGHAI HENLIUS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Shanghai Henlius Biotech, Inc. OTC Markets

Equities

SGBCF

CNE100003N76

Market Closed - OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Shanghai Henlius Biotech, Inc. -.--% -.--%
05-14 Shanghai Henlius Biotech Gets Go-Ahead for Clinical Trials of Breast Cancer Drug in China MT
05-14 Shanghai Henlius Biotech, Inc. Announces Approval of Application for Clinical Trials of HLX78 (lasofoxifene) by the National Medical Products Administration CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. 2696 Stock
  4. SGBCF Stock
  5. Revisions Shanghai Henlius Biotech, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW